Electronic publishing

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Electronic labeling submission of drug marketing information using the structured product labeling (SPF) format is now mandatory by the FDA since 2005. The SPF has now replaced the portable document format (PDF) as the standard acceptable submission form. The change from PDF to SPL has many advantages, one of which is to meet the new mandates in the new Medicare Prescription Drug Law. This new mandate will expedite the FDA’s processing, reviewing, and archiving of the labeling content.

Cite

CITATION STYLE

APA

Wallace, H. L. (2006). Electronic publishing. In The Process of New Drug Discovery and Development, Second Edition (pp. 481–482). CRC Press. https://doi.org/10.1201/9781420004236.ch26

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free